Sign In
to Vote &
Create Storyboards.
 
Pfizer and Medivation reportedly close to $14bn deal US pharmaceutical giant Pfizer is reportedly in advanced talks to buy cancer drug firm Medivation for about $14bn (£10.7bn).
5
0
0


Storyboard
Print
Share this Article

Recommended

  • {TITLE}
    {PUBLISHER} - {PUBLISHED_DATE}
    {VIEWS}
  • Create Storyboard